Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : QDEL save search
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-04-22 (Crawled : 08:00) - prnewswire.com
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 2.04%
H: 1.38%
C: 0.03%
OCGN | News 4 | $1.17 -6.4% -6.84% 7.3M
|
Health Technology
|
| O: 4.65%
H: 0.74%
C: -8.15%
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law Firm
Published: 2024-04-19 (Crawled : 11:00) - prnewswire.com
VFS | News | $2.49 2.89% 2.81% 2.8M
|
|
| O: -3.86%
H: 0.0%
C: 0.0%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
corporation deadline quidel
QuidelOrtho To Report First Quarter 2024 Financial Results
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.06%
first report financial results
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-04-16 (Crawled : 04:00) - prnewswire.com
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -2.85%
H: 0.27%
C: -1.87%
CKPT | $1.44 0.35% 0.35% 180K
|
Health Technology
|
| O: 2.31%
H: 0.0%
C: -4.52%
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -2.64%
H: 2.3%
C: 1.24%
vitros partnership test assay
ROSEN, LEADING INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
Published: 2024-04-03 (Crawled : 01:00) - prnewswire.com
LUXH | $0.9505 9.25% 8.47% 330K
|
|
| O: -0.71%
H: 2.86%
C: -2.86%
BCDRF | $4.978 -8.71% 100
|
Finance
|
| O: 3.9%
H: 4.33%
C: 4.33%
SAN | $5.05 1.2% 0.0% 4.9M
|
Finance
|
| O: 1.04%
H: 1.23%
C: 0.82%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -0.17%
H: 1.57%
C: 1.07%
corporation
Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected Strong Growth to $2.25 Billion by 2028 Amid Advancements in Cancer Treatment
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 1.14%
H: 4.36%
C: 3.16%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.1%
H: 0.18%
C: -1.25%
cancer treatment growth market
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
Published: 2024-03-06 (Crawled : 23:00) - biospace.com/
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 0.14%
H: 0.91%
C: -0.3%
quidel test health approval canada
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published: 2024-03-05 (Crawled : 05:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -0.09%
H: 0.86%
C: 0.6%
DGX | News | $137.55 0.62% 0.0% 1.6M
|
Health Services
|
| O: 0.38%
H: 0.69%
C: -1.01%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.32%
H: 0.22%
C: -0.2%
BIO | $278.21 -2.48% 0.0% 210K
|
Health Technology
|
| O: -0.53%
H: 1.08%
C: -0.59%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: 0.0%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 0.18%
H: 1.13%
C: -3.31%
report respiratory global rsv virus diagnostics growth market
Lateral Flow Assays Market Worth $16.8 billion | MarketsandMarkets™
Published: 2024-02-26 (Crawled : 15:30) - prnewswire.com
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: -0.55%
H: 0.08%
C: -0.36%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.13%
H: 0.38%
C: -0.68%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -0.7%
H: 0.9%
C: -1.48%
flow market
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-02-13 (Crawled : 00:00) - biospace.com/
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -3.51%
H: 2.61%
C: -0.49%
financial results
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 1.23%
H: 0.19%
C: -1.34%
report financial results
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-22 (Crawled : 13:30) - biospace.com/
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 0.34%
H: 2.43%
C: -0.07%
conference
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
Published: 2023-12-20 (Crawled : 00:00) - biospace.com/
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -0.16%
H: 0.62%
C: -2.57%
savanna clearance molecular platform
Isothermal Nucleic Acid Amplification Technology Market worth $8.83 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2023-11-24 (Crawled : 09:00) - prnewswire.com
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: 0.17%
H: 0.53%
C: 0.42%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: -0.06%
H: 0.95%
C: 0.95%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -0.55%
H: 1.54%
C: 1.52%
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: 0.17%
H: 0.53%
C: 0.42%
HOLX | $76.71 -0.62% -0.63% 910K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: -0.28%
GRFS | $6.4 -1.23% -1.25% 960K
|
Health Technology
|
| O: 1.55%
H: 1.63%
C: 0.71%
report technology market
QuidelOrtho to Participate in the Evercore ISI Conference
Published: 2023-11-16 (Crawled : 00:00) - biospace.com/
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 0.8%
H: 3.2%
C: 2.49%
conference
Asia Pacific Emerges as a High-Growth Region in the Cardiac Marker Testing Market, Fueled by Government Investments and Growing Clinical Laboratories
Published: 2023-11-10 (Crawled : 23:00) - prnewswire.com
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
| Email alert
Add to watchlist
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
| Email alert
Add to watchlist
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
| Email alert
Add to watchlist
BIO | $278.21 -2.48% 0.0% 210K
|
Health Technology
| Email alert
Add to watchlist
investments cardiac asia growing
Global Self Testing Market Analysis Report 2023-2028: Breakdown by Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, & COVID-19 Testing
Published: 2023-11-08 (Crawled : 10:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.66%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.04%
H: 0.54%
C: -0.5%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -0.15%
H: 1.46%
C: -1.98%
OSUR | News | $5.49 -0.72% -0.73% 760K
|
Health Technology
|
| O: 1.04%
H: 6.04%
C: 1.81%
covid-19 pregnancy report urine cholesterol blood global market
Cardiac Marker Testing Market Worth $6.9 billion | MarketsandMarkets
Published: 2023-10-25 (Crawled : 14:30) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -5.77%
H: 3.75%
C: 2.41%
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: -2.04%
H: 0.5%
C: -0.09%
BIO | $278.21 -2.48% 0.0% 210K
|
Health Technology
|
| O: -2.05%
H: 0.0%
C: -2.49%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: -0.35%
H: 1.52%
C: -1.06%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.89%
H: 0.09%
C: -1.04%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: -1.71%
H: 1.2%
C: -2.09%
cardiac market
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 2.75%
H: 0.0%
C: 0.0%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: -8.35%
results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.